The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Good Afternoon and welcome to HotCopper Highlights wrapping up Week 41 of the year, I’m Jon Davidson. In this segment the top stocks most watched and most discussed by you, HotCopper users, let’s get straight into it starting with the most viewed. 

Findi, a fintech that’s ultimately rolling out ATMs in parts of India where there aren’t any, has had a very uniquely HotCopper experience this week after a user claiming to be a former member of staff, apparently drunk, took to the forums of this very website to allege the company is up to no good; Findi’s legal team will be getting involved. Just another day at the office. 

PainChek, meanwhile, a company developing an app that’s ultimately used in aged care homes, this week gathered a lot of attention when it shot up on no news one day before revealing its app has been approved by the FDA for use in the States; now that’s in the bag, the company needs to get about actually selling it. 

Finally, Mesoblast back in favour with HotCopper’s daily users as that stock appears to be heading back to former darling status now that its stem cell drug Ryoncil appears to be gathering momentum in the USA when it comes to sales. 

And what about the most discussed stocks? 

Race Oncology has been generating a lot of chatter this week after the stock hit an all time high after revealing its figured out the mechanism of action behind its flagship drug Bisantrene, that matters because the company believes it effectively has a chemo drug without the side effects, and now they can presumably further optimise that drug. 

Elsewhere, Trigg Minerals remains of interest as the company continues sniffing around the US critical metals market; on Friday the company revealed it continues to assess options for listing on the NASDAQ, including a potential SPAC listing which can be controversial, but for now, it’s pretty much just thinking about it. 

And fintech Stakk remains popular with users after striking a deal with Robinhood in recent history and then inking another deal with US teclo giant T-Mobile. Both of those announcements came ahead of a $15M placement currently being digested by holders and skeptics alike. 

That’s HotCopper Highlights for this week, I’m Jon Davidson, have a great weekend and we’ll see you on Monday. 

More From The Market Online
The Market Online Video

Market Close: ASX correction running out of steam; banks still a worry & NVIDIA looms

Good Afternoon and welcome to HotCopper’s Market Close for Wednesday, I’m Jon Davidson.
Giving up

HotCopper users balk as Anson Resources flags second cap raise since August

Anson Resources has managed to resolutely irritate almost all HotCopper users commenting on the announcement threads…
European Medicine Agency headquarters

Prescient Therapeutics jumps +15% on EU regulator interest in PTX-100

Prescient Therapeutics has jumped +15% after EU drug regulator European Medicines Agency awarded orphan drug designation.
Pile of gold

Aus’ Gold and Copper pops +14% on dull day as near-surface gold rouses excitement

Australian Gold and Copper has news of potential gold mineralised systems near surface on-site at its…